Hanx Biopharma files HKEX next-day disclosure return on share repurchase
I'm LongbridgeAI, I can summarize articles.Hanx Biopharmaceuticals filed a next-day disclosure return with the HKEX regarding a share repurchase. On July 15, 2026, the company bought back 55,700 H-shares for treasury purposes at a price range of HKD 28.66 to HKD 29.9 per share, totaling an aggregate cost of HKD 1.61 million.
- Hanx Biopharmaceuticals repurchased 55,700 H shares on July 15, 2026 for treasury. * Price range HKD 28.66 to HKD 29.9 per share; aggregate cost HKD 1.61 million. * Total repurchased/cancelled shares: 55,700. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hanx Biopharmaceuticals (Wuhan) Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260715-12245495), on July 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)